Staar Surgical (STAA) Liabilities and Shareholders Equity (2010 - 2026)

Staar Surgical (STAA) has 17 years of Liabilities and Shareholders Equity data on file, last reported at $451.1 million in Q2 2026.

• Quarterly Liabilities and Shareholders Equity fell 1.37% year-over-year to $451.1 million in Q2 2026, while the trailing twelve-month figure through Apr 2026 was $1.8 billion (up 18.94% YoY) and the FY2026 annual result came in at $451.7 million, up 14386.14% from the prior year.
• Liabilities and Shareholders Equity was little changed at $451.1 million in Q2 2026, from $451.7 million in the prior quarter.
• In the past five years, Liabilities and Shareholders Equity ranged from a high of $537.6 million in Q3 2024 to a low of $1.3 million in Q4 2022.
• A 5-year average of $368.1 million and a median of $440.7 million in 2023 frame the typical range for Liabilities and Shareholders Equity.
• Annual changes were most pronounced in 2025 — Liabilities and Shareholders Equity dropped 15.11% — and 2026, when it surged 14386.14%.
• Tracing STAA's Liabilities and Shareholders Equity over 5 years: stood at $1.3 million in 2022, then soared by 110.65% to $2.8 million in 2023, then rose by 12.64% to $3.1 million in 2024, then jumped by 14536.37% to $456.4 million in 2025, then slipped by 1.15% to $451.1 million in 2026.
• The last three Liabilities and Shareholders Equity figures came in at $451.1 million (Q2 2026), $451.7 million (Q1 2026), and $456.4 million (Q3 2025), per Business Quant data.